Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 55
  • Start Date: March 31, 2021
Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With Inhibitors
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 48
  • Start Date: January 1, 2021
Clinical and Health-related Outcome of rFVIIIFc Prophylaxis in Patients With Haemophilia A
Clinical Trial
  • Status: Enrolling by invitation
  • Intervention Type: Biological
  • Participants: 13
  • Start Date: November 3, 2020
Long-Term Follow-up of Subjects Who Were Treated With SB-318, SB-913, or SB-FIX, for Targeted Genome Editing Into the Albumin Gene in the Liver
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 15
  • Start Date: October 2020
Monitoring and Pharmacodynamics Effect of Recombinant Factor IX Fc in Severe Haemophilia B Patients: a Real-life Study
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 10
  • Start Date: June 1, 2020
Lentiviral FIX Gene Therapy for Hemophilia B
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 22
  • Start Date: January 16, 2020
Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Genetic
  • Participants: 9
  • Start Date: October 16, 2019
Gene Therapy for Chinese Hemophilia B With Adeno-associated Virus (AAV) Vector
Showing 1-12 of 44